- Home
- NXGL vs NUWE Comparison
NXGL vs NUWE Comparison
Compare NXGL & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXGL | NUWE |
|---|---|---|
| Founded | 1997 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 3.2M |
| IPO Year | 2019 | 2012 |
Fundamental Metrics
Financial Performance| Metric | NXGL | NUWE |
|---|---|---|
| Price | $0.18 | $0.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | 138.0K | ★ 2.7M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,421,000.00 | $8,270,000.00 |
| Revenue This Year | $50.77 | $11.14 |
| Revenue Next Year | $46.15 | $18.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 31.46 | N/A |
| 52 Week Low | $0.24 | $0.08 |
| 52 Week High | $2.89 | $6.40 |
Technical Indicators
Market Signals| Indicator | NXGL | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 25.63 | 41.03 |
| Support Level | N/A | $0.71 |
| Resistance Level | $0.38 | $1.20 |
| Average True Range (ATR) | 0.03 | 0.09 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 16.72 | 2.97 |
Price Performance
Historical ComparisonAbout NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
About NUWE Nuwellis Inc.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.